Reports Q1 revenue $646.9M, consensus $641.78M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CHE:
- CHE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Positive Outlook for Chemed’s Roto-Rooter Segment Justifies Buy Rating Amid Rising Demand and Revenue Growth
- Chemed price target raised to $667 from $633 at RBC Capital
- Chemed Corporation Reports Strong Q4 2024 Results
- Chemed’s Earnings Call: VITAS Shines, Roto-Rooter Struggles